Yizun Biopharmaceutical

Yizun Biotech offers cell therapy solutions, including universal technologies for treating solid tumors and allogeneic cells.

Launch date

Apr 2018

Market cap

Enterprise valuation

小营街道 Zhejiang (HQ)

Date	Investors	Amount	Round
Apr 2018	University of Washington Fred Hutchinson Cancer Research Center	N/A	Spinout
Jun 2019	Livzon Pharmaceutical Group	N/A	Early VC
Jan 2022*	Shenzhen Capital Group VMS Capital Tao Capital Partners TEDA Venture Capital Panacea Venture	N/A	Series A
May 2022	Shenzhen Capital Group Dingpei Group	CNY100m	Series A
Apr 2024*	Tigeryeah Capital Tailong Investment Hangzhou Binjiang 5050 Fund	CNY100m	Series A
Total Funding		AUD42.5m

Recent News about Yizun Biopharmaceutical